Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar-Apr;6(2):211-24.
doi: 10.1002/wrna.1268. Epub 2014 Oct 28.

Understanding the potential of hepatitis C virus internal ribosome entry site domains to modulate translation initiation via their structure and function

Affiliations
Review

Understanding the potential of hepatitis C virus internal ribosome entry site domains to modulate translation initiation via their structure and function

Anas Khawaja et al. Wiley Interdiscip Rev RNA. 2015 Mar-Apr.

Abstract

Translation initiation in the hepatitis C virus (HCV) occurs through a cap-independent mechanism that involves an internal ribosome entry site (IRES) capable of interacting with and utilizing the eukaryotic translational machinery. In this review, we focus on the structural configuration of the different HCV IRES domains and the impact of IRES primary sequence variations on secondary structure conservation and function. In some cases, multiple mutations, even those scattered across different domains, led to restoration of the translational activity of the HCV IRES, although the individual occurrences of these mutations were found to be deleterious. We propose that such observation may be attributed to probable long-range inter- and/or intra-domain functional interactions. The precise functioning of the HCV IRES requires the specific interaction of its domains with ribosomal subunits and a subset of eukaryotic translation initiation factors (eIFs). The structural conformation, sequence preservation and variability, and translational machinery association with the HCV IRES regions are also thoroughly discussed, along with other factors that can affect and influence the formation of translation initiation complexes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A stepwise demonstration of the hepatitis C virus internal ribosome entry site (HCV IRES) translation initiation pathway. The specified arrangement of the HCV IRES domains and ribosomal subunits along with the particular placement of a subset of canonical eukaryotic translation initiation factors (eIFs) required to assemble the pre-initiation 48S and 80S complexes are depicted. The red arrows indicate eIF2-GTP-independent translation under stress (upon eIF2α phosphorylation), when protein synthesis continues with eIF5B or other reported factors (eIF2A, eIF2D). Mutations in different HCV IRES domains that may inhibit particular stages of translation complex formation are shown under the arrows.
Figure 2
Figure 2
The proposed secondary structure of the hepatitis C virus internal ribosome entry site (HCV IRES),, with three-dimensional structures of domains II-IV resolved by NMR and X-ray crystallography.– The domains of the HCV IRES are labeled. Nucleotides colored in cyan indicate the highly conserved regions of the IRES, whereas nucleotides in red denote mutations in the domains involved in a proposed long-range inter or intra-domain interaction or an unusual translational activity. The colors in the secondary structure correspond to the 3D structure. The PDB entries for the HCV IRES domains are domains II (1P5P), IIIb (1KP7), IIIc (1IDV), IIIabc (1KH6), IIId (1F84), IIIe (1 F85), and IIIef (3T4B).

References

    1. Gravitz L. A smouldering public-health crisis. Nature. 2011;474:S2–S4. - PubMed
    1. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436:967–972. - PubMed
    1. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006;130:231–264. - PubMed
    1. Sofia MJ, Bao D, Chang W, Du JF, Nagarathnam D, Rachakonda S, Reddy PG, Ross BS, Wang PY, Zhang HR. Discovery of a β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J Med Chem. 2010;53:7202–7218. et al. - PubMed
    1. Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR. Sofosbuvir for previously untreated chronic hepatitis C infection. New Engl J Med. 2013;368:1878–1887. et al. - PubMed

Publication types

MeSH terms

LinkOut - more resources